Ascentage Pharma Group International (HKG:6855)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
45.26
+1.72 (3.95%)
Mar 6, 2026, 4:08 PM HKT

HKG:6855 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
16,658-----
Market Cap Growth
39.70%-----
Enterprise Value
16,72900000
Debt / Equity Ratio
2.546.0925.424.390.880.63
Debt / EBITDA Ratio
-1.48-5.66-2.23-2.14-1.13-0.77
Debt / FCF Ratio
--12.30-2.33-2.09-1.04-0.62
Net Debt / Equity Ratio
0.081.5411.620.74-0.53-0.58
Net Debt / EBITDA Ratio
-0.05-1.38-0.87-0.360.690.72
Net Debt / FCF Ratio
--3.00-0.91-0.350.630.57
Asset Turnover
0.140.380.080.070.010.01
Inventory Turnover
4.702.562.383.291.69-
Quick Ratio
1.531.261.421.855.213.91
Current Ratio
1.541.261.441.865.223.91
Return on Equity (ROE)
-124.37%-235.32%-386.28%-107.45%-75.18%-78.02%
Return on Assets (ROA)
-41.45%-15.56%-33.40%-31.08%-39.59%-48.82%
Return on Invested Capital (ROIC)
-116.04%-37.32%-83.61%-92.76%-129.70%-202.62%
Return on Capital Employed (ROCE)
-71.39%-25.71%-51.04%-39.80%-48.77%-58.14%
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.